Correction: Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics (Cancer Cell (2016) 30(3) (499–500) (S1535610816000350) (10.1016/j.ccell.2016.01.006))
Lalaoui N., Hänggi K., Brumatti G., Chau D., Nguyen NYN., Vasilikos L., Spilgies LM., Heckmann DA., Ma C., Ghisi M., Salmon JM., Matthews GM., de Valle E., Moujalled DM., Menon MB., Spall SK., Glaser SP., Richmond J., Lock RB., Condon SM., Gugasyan R., Gaestel M., Guthridge M., Johnstone RW., Munoz L., Wei A., Ekert PG., Vaux DL., Wong WWL., Silke J.
© 2016 Elsevier Inc. (Cancer Cell 29, 145–158; February 8, 2016) After the publication of this paper, the authors found four small errors in Figure 3. In Figure 3A, the label p38P on the right side of the second blot from the top should be p38, and the label MK2 on the right side of the second blot from the bottom should be MK2P. In addition, the pTAK1 and pMK2 blots in Figure 3C were inadvertently stretched out during figure preparation. These errors have now been corrected here and in the article online. The authors apologize for these errors and any inconvenience that may have resulted.